Vita 34 AG
XETRA:V3V
Vita 34 AG
Common Shares Outstanding
Vita 34 AG
Common Shares Outstanding Peer Comparison
Competitive Common Shares Outstanding Analysis
Latest Figures & CAGR of Competitors
Company | Common Shares Outstanding | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Vita 34 AG
XETRA:V3V
|
Common Shares Outstanding
€17.4m
|
CAGR 3-Years
62%
|
CAGR 5-Years
34%
|
CAGR 10-Years
19%
|
|
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
Common Shares Outstanding
€293.4m
|
CAGR 3-Years
0%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
0%
|
Fresenius SE & Co KGaA
XETRA:FRE
|
Common Shares Outstanding
€563.2m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
E
|
Euroeyes International Eye Clinic Ltd
HKEX:1846
|
Common Shares Outstanding
HK$333.2m
|
CAGR 3-Years
0%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
Synlab AG
XETRA:SYAB
|
Common Shares Outstanding
€219.8m
|
CAGR 3-Years
0%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Vita 34 AG's Common Shares Outstanding?
Common Shares Outstanding
17.4m
EUR
Based on the financial report for Dec 31, 2023, Vita 34 AG's Common Shares Outstanding amounts to 17.4m EUR.
What is Vita 34 AG's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 10Y
19%
Over the last year, the Common Shares Outstanding growth was 10%. The average annual Common Shares Outstanding growth rates for Vita 34 AG have been 62% over the past three years , 34% over the past five years , and 19% over the past ten years .